1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
Hunt et al. • 2015 • Bioorg Med Chem Lett. 2015;25(24):5720-5.
© 2024 Corcept Therapeutics, Incorporated
Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.
Agrawal et al. • 2011 • Mol Pharmacol. 2011;80(3):389-99.
Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.
Andrade et al. • 2012 • J Neural Transm (Vienna). 2012;119(3):337-44.
Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™).
Webster et al. • 2017 • Br J Pharmacol. 2017;174(5):396-408.
High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer
Veneris et al • 2017 • Gynecol Oncol.
Evaluation of evidence of adrenal insufficiency in trials of normocortisolemic patients treated with mifepristone.
Yuen et al. • 2017 • J Endocr Soc. 2017;1(4):237-246.
The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness.
Moraitis et al. • 2017 • J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):114-120.
U500 Insulin Screening of Diabetic Patients Uncovers a Large Amount of Undiagnosed Hypercortisolism Consistent With Cushing’s Syndrome
Editorial Team • 2017 • Diabetes
Mifepristone improves octreotide efficacy in resistant ectopic Cushing’s syndrome.
Moraitis AG, Auchus RJ. • 2016 • Case Rep Endocrinol. 2016;2016:8453801.
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.
Pineau et al. • 2016 • Neurobiol Aging. 2016;45:109-122.